4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000124
Director sold 100 shares at an average $1,178.69 ($117,869)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
RYAN ARTHUR F · Director
Table I: Non-derivative
20 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-03 | Sale : show line 1 in the form 10b5-1 | −4 | $1,166.52 | $4,666 | 17,778 | D |
| 2024-09-03 | Sale : show line 2 in the form 10b5-1 | −1 | $1,167.27 | $1,167 | 17,777 | D |
| 2024-09-03 | Sale : show line 3 in the form 10b5-1 | −4 | $1,168.99 | $4,676 | 17,773 | D |
| 2024-09-03 | Sale : show line 4 in the form 10b5-1 | −4 | $1,170.40 | $4,682 | 17,769 | D |
| 2024-09-03 | Sale : show line 5 in the form 10b5-1 | −16 | $1,172.75 | $18,764 | 17,753 | D |
| 2024-09-03 | Sale : show line 6 in the form 10b5-1 | −8 | $1,174.32 | $9,395 | 17,745 | D |
| 2024-09-03 | Sale : show line 7 in the form 10b5-1 | −8 | $1,175.66 | $9,405 | 17,737 | D |
| 2024-09-03 | Sale : show line 8 in the form 10b5-1 | −4 | $1,176.82 | $4,707 | 17,733 | D |
| Open-market sales · 100 sh · avg $1,178.69 · $117,869 | ||||||
Loading xslF345X05/edgardoc.xml…